COVID-19: Yole’s analysts point out the impacts on the bioMEMS industry
Product Related
“It is now a reality, the world, and particularly the healthcare sector, will have experienced a before, and an after, the COVID-19 outbreak.” asserts Jérôme Mouly, Senior Technology & Market Analyst and Business Developer at Yole Développement (Yole). “The pandemic has strongly hit the medical devices and IVD sector with an impact on sales as well as on applications and usage. However, the impact is slightly different in the healthcare sector than in other domains, such as consumer or automotive markets. Moreover, it is highly application-related”.
BioMEMS devices, defined as MEMS sensors and microfluidic devices integrated into medical devices and used for IVD and life sciences, are reflecting the market demand for the products in which they are integrated.
Indeed, the global bioMEMS market was worth US$3.7 billion in 2019 and is expected to reach US$6.3 billion in 2025 with a CAGR between 2019 and 2025 of 9.2% in revenue. The microfluidic chips market represents 85% of the market due to the huge market for polymer-based microfluidic chips. This is followed by the pressure sensor market.
In volume, the highest growth expected on the next five years is for MUT for medical imaging and IVUS, and for inertial MEMS (especially IMU) related to fall detection and activity tracking. The larger market segments using mainly microfluidic chips are pharmaceutical research and IVD testing.
The key drivers for the use of MEMS and microfluidic technologies are:
- IT environment and telecommunication (5G network is one major contributor).
- Cost pressure on healthcare: development of systems for home care, point of care and medical wearables to monitor patients out of hospital.
- The contribution of advanced technologies to reduced power and miniaturized systems.
In this context, Yole investigates disruptive technologies and related markets in depth, in order to point out the latest innovations and to underline the business opportunities.
In this regard, the Photonic & Sensing team delivers three dedicated reports to highlight the latest technical and market trends: BioMEMS Market and Technology, Point-of-Need 2020 – Including PCR-Based Testing, and Thermal Imagers and Detectors 2020 – COVID-19 Outbreak Impact – Preliminary.
Released today, the BioMEMS market and technology report gives a comprehensive overview of MEMS devices, including pressure sensors, MEMS microphones, inertial MEMS, microfluidic chips, microdispensers, optical MEMS, MUT, flowmeters… All of them are integrated or used in the life sciences and healthcare domains. This study provides the latest major information and key facts of the bioMEMS industry.
Taking into account the COVID-19 impacts at the sensor and end system level, analysts examine the bioMEMS market and propose a complete review of the industry and future trends. Including market forecasts, main player market shares, ecosystem, supply chain and market and technology trends, this report provides a detailed description of this industry. This report also identifies the emerging bioMEMS sensors: design, integration, and usage challenges.
What are the economic and technological challenges? What are the impacts of COVID-19 on the bioMEMS industry in both the short and long term? What are the key drivers? Who are the suppliers to watch, and what innovative technologies are they working on? Yole presents today its vision of the bioMEMS industry… More info.